UNMC to start third phase of federal COVID-19 drug trial
The third phase of the trial, which launched in February, will pair remdesivir with a type of interferon used to treat MS and some kinds of hepatitis.
The third phase of the trial, which launched in February, will pair remdesivir with a type of interferon used to treat MS and some kinds of hepatitis.